These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis. Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730 [TBL] [Abstract][Full Text] [Related]
26. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients. Bagheri N; Taziki O; Falaknazi K Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474 [TBL] [Abstract][Full Text] [Related]
27. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients. Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714 [TBL] [Abstract][Full Text] [Related]
28. C-reactive protein in hypertension: clinical significance and predictive value. Schillaci G; Pirro M Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):500-8. PubMed ID: 16979884 [TBL] [Abstract][Full Text] [Related]
29. [Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study]. Barrios V; Gómez-Huelgas R; Rodríguez R; de Pablos-Velasco P Rev Esp Cardiol; 2008 Nov; 61(11):1159-67. PubMed ID: 19000491 [TBL] [Abstract][Full Text] [Related]
30. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587 [TBL] [Abstract][Full Text] [Related]
31. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A; Freiberg JJ; Nordestgaard BG Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664 [TBL] [Abstract][Full Text] [Related]
32. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis. García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465 [TBL] [Abstract][Full Text] [Related]
33. [Age related macular degeneration and C-reactive protein]. Stefan C; Dumitrica DM; Tebeanu E; Sapundgieva A; Dragomir L; Cristea I Oftalmologia; 2008; 52(3):73-6. PubMed ID: 19149122 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
35. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease. Habib SS J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446 [TBL] [Abstract][Full Text] [Related]
36. Asthma is an independent risk for elevation of plasma C-reactive protein levels. Kasayama S; Tanemura M; Koga M; Fujita K; Yamamoto H; Miyatake A Clin Chim Acta; 2009 Jan; 399(1-2):79-82. PubMed ID: 18838067 [TBL] [Abstract][Full Text] [Related]
37. Serum and saliva sialic acid in periodontitis patients with and without cardiovascular disease. Oktay S; Basar I; Emekli-Alturfan E; Malali E; Elemek E; Ayan F; Koldas L; Noyan U; Emekli N Pathophysiol Haemost Thromb; 2010; 37(2-4):67-71. PubMed ID: 21372547 [TBL] [Abstract][Full Text] [Related]
38. Relation of educational level to inflammation-sensitive biomarker level. Steinvil A; Shirom A; Melamed S; Toker S; Justo D; Saar N; Shapira I; Berliner S; Rogowski O Am J Cardiol; 2008 Oct; 102(8):1034-9. PubMed ID: 18929705 [TBL] [Abstract][Full Text] [Related]
39. Changes in plasma lipids with psychosocial stress are related to hypertension status and the norepinephrine stress response. Wirtz PH; Ehlert U; Bärtschi C; Redwine LS; von Känel R Metabolism; 2009 Jan; 58(1):30-7. PubMed ID: 19059528 [TBL] [Abstract][Full Text] [Related]
40. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Corson MA; Jones PH; Davidson MH Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]